Addressing increasingly resistant drugs by infectious agents
Drug Target Review
SEPTEMBER 4, 2023
7,9 Dihydrofolate reductase-thymidylate synthase (DHFR) have been successfully exploited for the therapy of bacterial infections and other parasitic diseases such as malaria. 2013): Exploring the Trypanosoma brucei Hsp83 Potential as a Target for Structure Guided Drug Design, PLOS Neglected Tropical disease. Trends in Parasitology. (35):
111 
Let's personalize your content